SCHEMBL14295705

SCHEMBL14295705

c1ccc(-c2cc(-c3cccc(N(c4ccccc4)c4cccc5c4oc4ccccc45)c3)cc(-c3cccc(N(c4ccccc4)c4cccc5c4oc4ccccc45)c3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.39
▸ PLA2G4A P47712 4/20 0.39
▸ ALOX5 P09917 3/20 0.38
▸ PLA2G10 O15496 1/20 0.36
▸ MAPT P10636 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ AHR P35869 1/20 0.34
▸ GABRP O00591 1/20 0.34
▸ GABRD O14764 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ TNKS O95271 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ ABCB1 P08183 1/20 0.34
▸ PARP1 P09874 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14295710 0.97 PLA2G2A (0.40) PLA2G2APLA2G4AALOX5PLA2G10MAPT
SCHEMBL17126317 0.97 ALOX5 (0.40) PLA2G2APLA2G4AALOX5PLA2G10MAPT
SCHEMBL14295694 0.97 ALOX5 (0.40) PLA2G2APLA2G4AALOX5PLA2G10MAPT
SCHEMBL14295698 0.96 PLA2G2A (0.41) PLA2G2APLA2G4AALOX5PLA2G10MAPT
SCHEMBL14295689 0.96 ALOX5 (0.42) PLA2G2APLA2G4AALOX5PLA2G10MAPT
SCHEMBL24471688 0.96 ALOX5 (0.40) PLA2G2APLA2G4AALOX5PLA2G10MAPT
SCHEMBL14295685 0.96 ALOX5 (0.40) PLA2G2APLA2G4AALOX5PLA2G10MAPT
SCHEMBL14295691 0.95 ALOX5 (0.41) PLA2G2APLA2G4AALOX5PLA2G10MAPT
SCHEMBL24471723 0.95 ALOX5 (0.41) PLA2G2APLA2G4AALOX5PLA2G10MAPT
SCHEMBL24472295 0.95 ALOX5 (0.41) PLA2G2APLA2G4AALOX5PLA2G10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-12-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120319091-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME INMT, TYR, ALKBH2 PLA2G2A 4425/4885PLA2G4A 4488/4885ALOX5 1298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback